SavedAdd your journal

Journals / Türk Geriatri Dergisi / 2019 / Cilt: 22 - Sayı: 4

PROGNOSTIC FACTORS AND SURVIVAL OF ELDERLY WOMEN WITH BREAST CANCER AGED ≥70 YEARS

YETMİŞ YAŞ VE ÜZERİ MEME KANSERLİ YAŞLI KADINLARDA PROGNOSTİK FAKTÖRLER VE SAĞKALIM

Berrin İNANÇ
Özlem MERMUT
Pages
426–433
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In thisstudy, we aimed to investigate prognostic factors affecting survival in women aged ≥70 yearsof age and older with breast cancer.Materials and Method: A total of 148 female patients aged ≥70 years who were admittedto the University of Health Sciences Istanbul Training and Research Hospital RadiationOncology clinic between 2011 and 2017 were evaluated.Results: Age (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: In the treatment of geriatric patients with breast cancer, each patient shouldbe treated according to his/her specific disease, performance status, and biological age.
📊
Key Findings & Data:Introduction: In the treatment of geriatric patients with breast cancer, each patient shouldbe treated according to his/her specific disease, performance status, and biological age.
💡
Conclusion & Impact:In thisstudy, we aimed to investigate prognostic factors affecting survival in women aged ≥70 yearsof age and older with breast cancer.Materials and Method: A total of 148 female patients aged ≥70 years who were admittedto the University of Health Sciences Istanbul Training and Research Hospital RadiationOncology clinic between 2011 and 2017 were evaluated.Results: Age (p
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: In the treatment of geriatric patients with breast cancer, each patient shouldbe treated according to his/her specific disease, performance status, and biological age. In thisstudy, we aimed to investigate prognostic factors affecting survival in women aged ≥70 yearsof age and older with breast cancer.Materials and Method: A total of 148 female patients aged ≥70 years who were admittedto the University of Health Sciences Istanbul Training and Research Hospital RadiationOncology clinic between 2011 and 2017 were evaluated.Results: Age (p

Özet

Giriş: Meme kanseri olan geriatrik hastaların tedavisinde, her hasta kendi hastalığına, performans durumuna ve biyolojik yaşına göre tedavi edilmelidir. Bu çalışmada, meme kanserli, ≥70 yaş ve üstü yaşlı kadınlarda sağkalımı etkileyen prognostik faktörleri araştırmayı amaçladık. Gereç ve Yöntem: 2011-2017 yılları arasında Sağlık Bilimleri Üniversitesi İstanbul Eğitim ve Araştırma Hastanesi Radyasyon Onkolojisi kliniğine başvuran, yaşları ≥70 ve üstünde olan toplam 148 kadın hasta değerlendirildi. Bulgular: Yaş (p

🔖

Cite This Article

İNANÇ, B., MERMUT, Ö. (2022). PROGNOSTIC FACTORS AND SURVIVAL OF ELDERLY WOMEN WITH BREAST CANCER AGED ≥70 YEARS. Türk Geriatri Dergisi, Cilt: 22 - Sayı: 4, 426–433. https://ajindex.com/articles/623604

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA) The Lancet Oncology 2012;13(4):e148–60. (PMID:22469125)
  2. Hutchins F, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341(27):2061-7. (PMID:10615079)
  3. Turner N, Zafarana E, Sanna G, Mottino G, Biganzoli L. The best treatment for older patients with breast cancer. EJC Suppl 2013;11(2):299-300. (PMID:26217152)
  4. Chu C, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival and mortality rates. National Cancer Inst 1996;88(21):1571-9. (PMID:8901855)
  5. Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32(24):2595-603. (PMID:25071125)
  6. Tang SW, Parker H, Winterbottom L, et al. Early primary breast cancer in the elderly - pattern of presentation and treatment. Surg Oncol 2011;20(1):7- 12. (PMID:19679464)
  7. Lei L, Yu X, Chen B, et al. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study. PLoS One 2016;11(5):e0155132. (PMID:27232881)
  8. Lee CM, Zheng H, Tan VK, et al. Surgery for early breast cancer in the extremely elderly leads to improved outcomes-an Asian population study. Breast 2017;36:44–8. (PMID:28942237)
  9. Wildiers H, Kunkler I, Biganzoli L, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007;8(12):1101–15. (PMID:18054880)
  10. Land L H, Dalton SO, Jensen MB, Ewertz M. Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. British Journal of Cancer 2012;107(11):1901-7. (PMID:23079577)
  11. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. Journal of the National Cancer Institute 2011;103(14):1101-11. (PMID:21719777)
  12. Klepin HD, Pitcher BN, Ballman KV, et al. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract 2014